Inside the push to make intellectual property work for African pharma

Africa’s leadership aims to significantly scale up the amount of pharmaceutical manufacturing happening on the continent, which could help create greater levels of health security for the population.

But there are myriad challenges.

Access to licenses to manufacture products is one because pharmaceutical patent holders are largely overseas. And there aren’t enough partnerships where foreign companies guide local producers on how to make their products.

This article is free to read - just register or sign in

Access news, newsletters, events and more.

Join us